Teva's decision to move North American HQ leaves other sites in jeopardy

Teva Pharmaceutical Industries Ltd. will relocate its U.S. headquarters into a planned New Jersey facility, the company confirmed on Thursday. The Israeli drugmaker (NYSE: TEVA), which currently hosts its U.S. headquarters in the Philadelphia area and a specialty pharmaceutical business in Overland Park, announced in December that it would cut 14,000 jobs and consolidate its seven U.S. locations into one main campus. The planned headquarters at Parsippany-Troy Hills will involved expanding an existing…
Source: bizjournals.com Health Care:Physician Practices headlines - Category: American Health Authors: Source Type: news